Reuters -- Forest Laboratories said on Tuesday that its fiscal fourth-quarter earnings fell as lower sales of its antidepressant Lexapro eroded higher sales of its drugs for Alzheimer’s disease and hypertension.
Reuters -- Forest Laboratories said on Tuesday that its fiscal fourth-quarter earnings fell as lower sales of its antidepressant Lexapro eroded higher sales of its drugs for Alzheimer’s disease and hypertension.
